Insider Buying: Ralliant (NYSE:RAL) Director Buys $82,500.00 in Stock

Key Points

  • Ralliant director Anelise Angelino Sacks purchased 2,000 shares on Feb. 9 at $41.25 each for a total of $82,500, boosting her stake by 58.77% to 5,403 shares (worth ~$222,874).
  • The company reported a modest quarterly beat (EPS $0.69 vs. $0.67) raised FY2026 guidance (2.220–2.420 EPS) and announced a quarterly dividend of $0.05 per share (0.5% yield).
  • Significant headwinds remain, including a reported $1.4 billion non‑cash goodwill impairment, multiple securities‑law investigations, analyst price‑target cuts, and a ~58.7% jump in short interest.

Ralliant Corporation (NYSE:RAL - Get Free Report) Director Anelise Angelino Sacks bought 2,000 shares of the company's stock in a transaction that occurred on Monday, February 9th. The stock was purchased at an average cost of $41.25 per share, with a total value of $82,500.00. Following the acquisition, the director directly owned 5,403 shares in the company, valued at $222,873.75. This trade represents a 58.77% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.

Ralliant Price Performance

NYSE:RAL opened at $43.11 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. The business's 50-day simple moving average is $51.26 and its two-hundred day simple moving average is $46.64. The stock has a market cap of $4.86 billion and a PE ratio of 33.94. Ralliant Corporation has a 52 week low of $37.27 and a 52 week high of $57.02.

Ralliant (NYSE:RAL - Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, topping analysts' consensus estimates of $0.67 by $0.02. The business had revenue of $554.60 million during the quarter, compared to the consensus estimate of $543.04 million. The firm's revenue for the quarter was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend




The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Monday, March 9th. Ralliant's dividend payout ratio (DPR) is 15.75%.

Wall Street Analysts Forecast Growth

RAL has been the subject of several research analyst reports. Barclays cut their target price on shares of Ralliant from $60.00 to $52.00 and set an "overweight" rating for the company in a research note on Monday. Citigroup dropped their price objective on shares of Ralliant from $61.00 to $51.00 and set a "buy" rating for the company in a report on Friday, February 6th. Truist Financial reduced their target price on Ralliant from $62.00 to $49.00 and set a "buy" rating on the stock in a report on Friday. Weiss Ratings downgraded Ralliant from a "hold (c)" rating to a "sell (d)" rating in a research report on Thursday, February 5th. Finally, Oppenheimer cut their price target on Ralliant from $60.00 to $50.00 and set an "outperform" rating for the company in a report on Friday. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $50.50.

Check Out Our Latest Report on RAL

More Ralliant News

Here are the key news stories impacting Ralliant this week:

  • Positive Sentiment: Multiple insider purchases (SVP Amir Kazmi, Director Kevin Bryant and others) signal management confidence and provide a buy signal to some investors. Read More. Read More.
  • Positive Sentiment: Research upgrades (Vertical Research upgraded RAL) can attract buyers and support near‑term demand. Read More.
  • Neutral Sentiment: Barclays lowered its price target (from $60 to $52) but kept an Overweight rating — still implies upside but reduces near‑term enthusiasm. Read More.
  • Neutral Sentiment: Citigroup trimmed its target to $51 — a modest negative to sentiment but still above current trading levels. Read More.
  • Negative Sentiment: Ralliant reported a $1.4 billion non‑cash goodwill impairment in its Test & Measurement segment and reduced FY2026 outlook — a substantive charge that led to analyst re‑ratings and is a key fundamental negative. Read More.
  • Negative Sentiment: Multiple law firms (including Levi & Korsinsky, Kessler Topaz, Kirby McInerney, Bragar Eagel & Squire and Kaplan Fox) have opened or publicized investigations into potential securities‑law violations tied to the timing and disclosure of the impairment and guidance — this raises regulatory, litigation and reputational risk. Read More.
  • Negative Sentiment: Short interest jumped ~58.7% in January to ~3.75M shares (about 3.3% of float) — increased bearish positioning can amplify downside pressure and intraday volatility.

Institutional Trading of Ralliant

A number of large investors have recently made changes to their positions in RAL. Allworth Financial LP lifted its stake in Ralliant by 134.4% in the fourth quarter. Allworth Financial LP now owns 511 shares of the company's stock worth $26,000 after purchasing an additional 293 shares during the last quarter. Rothschild Investment LLC raised its holdings in shares of Ralliant by 98.1% in the fourth quarter. Rothschild Investment LLC now owns 612 shares of the company's stock worth $31,000 after buying an additional 303 shares during the period. Keybank National Association OH lifted its stake in shares of Ralliant by 1.6% during the 4th quarter. Keybank National Association OH now owns 19,667 shares of the company's stock worth $1,001,000 after acquiring an additional 305 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its stake in shares of Ralliant by 1.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 25,800 shares of the company's stock worth $1,313,000 after acquiring an additional 400 shares during the last quarter. Finally, Arizona State Retirement System boosted its holdings in Ralliant by 1.2% during the 3rd quarter. Arizona State Retirement System now owns 33,566 shares of the company's stock valued at $1,468,000 after acquiring an additional 413 shares during the period.

Ralliant Company Profile

(Get Free Report)

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Ralliant?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Ralliant and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles